Sonia Benn, MD, is a Medical Oncologist and Hematologist at West Cancer Center.
Titles and Roles
- Medical Oncologist and Hematologist, West Cancer Center
- Assistant Affiliated Professor of Medicine, University of Tennessee Health Science Center, Memphis, TN
- Board member, Community Oncology Alliance, 2010-2011
Areas of Expertise
- Medical Oncology
West Cancer Center welcomed Sonia M. Benn, MD, a Hematology/Oncology specialist, to their team in February 2006. Dr. Benn is honored to be a part of the West Cancer Center team and is passionate about providing care to her patients that transcends the clinical to include the whole person – physically, emotionally, and socially. Dr. Benn treats patients at the Desoto office located in Southaven, MS, and plays a vital role in the healthcare community. Originally from Trinidad, West Indies, Dr. Benn grew up in Huntsville, AL. She is married to Lester, a local architect. In her leisure time, she enjoys cooking, playing the violin and piano and spending time with her husband and children.
Education and Training
Dr. Benn earned her medical degree from the University Of Tennessee Health Science Center College Of Medicine in Memphis in 1999 and subsequently completed her internship in Internal Medicine at Johns Hopkins University/Sinai Hospital in Baltimore, MD. In January 2001, she returned to Memphis and completed her residency in Internal Medicine and her fellowship in Hematology and Oncology at the University Of Tennessee Health Science Center College Of Medicine in Memphis.
- Winner of Best Oncologist, Desoto Times Tribune, 2012 & 2014
Dr. Benn’s research focused on “A Multicenter, Open-Label, Single Arm, Phase II Trial Investigating the Efficacy and Tolerability of Vinorelbine, Carboplatin and Trastuzumab for the First-Line Treatment of Metastatic Breast Cancer in Women with Her2+ Disease”. Dr. Benn examined the relationship of dehydroepiandrosterone (DHEA) and its sulfated ester with cardiovascular risk factors as a resident of The University of TN.
Dr. Benn is currently involved in the clinical trials in Hematology and Oncology conducted by West Cancer Center.
Dr. Benn’s recent publication discussed adjuvant trastuzumab (T) therapy in HER2 + breast cancer after ASCO 2005 in relation to patients’ attitudes and immediate economic burden.